doi:10.3390/ijms25031909 Price SAL, Nankervis A
Research published in Frontiers in Endocrinology found that GLP-1 receptor agonists can improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD)
The committee's recommendation to approve the majority of these peptides is a critical step forward in helping determine whether millions of Americans have safer, supervised access to these therapies
Some people on GLP-1 type medications report feeling intoxicated faster, likely because slowed stomach emptying changes alcohol absorption
And when I say that, I mean either were not good enough for them, or they shouldnt be for us because theyre expensive and weve got better things to be spending our money on. Tangira, a mother of a three-year-old daughter, used additional income from a promotion and increased work hours to fund her medication